Literature DB >> 1974006

HTLV-I/II antibodies in UK blood donors.

R Salker, J H Tosswill, J A Barbara, J Runganga, M Contreras, R S Tedder, N Parra-Mejia, P P Mortimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1974006     DOI： 10.1016/0140-6736(90)91856-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  HTLV-I screening in Britain.

Authors:  A Pagliuca; R Pawson; G J Mufti
Journal:  BMJ       Date:  1995-11-18

2.  Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors:  S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

3.  Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England.

Authors:  S Nightingale; D Orton; D Ratcliffe; S Skidmore; J Tosswill; U Desselberger
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

4.  Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.

Authors:  M Brennan; J Runganga; J A Barbara; M Contreras; R S Tedder; J A Garson; P W Tuke; P P Mortimer; L McAlpine; J H Tosswill
Journal:  BMJ       Date:  1993-11-13

5.  Severe refractory hypercalcaemia in HTLV-1 infection.

Authors:  C Mark B Edwards; Sarah J E Edwards; Rej-Paul Bhumbra; Tahseen A Chowdhury
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 18.000

6.  Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Authors:  R Fujino; K Kawato; M Ikeda; H Miyakoshi; M Mizukoshi; J Imai
Journal:  Jpn J Cancer Res       Date:  1991-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.